Evolv Technologies Holdings, INC Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
NASDAQ
Michael Ellenbogen, a Director of Evolv Technologies Holdings, Inc., sold 80,745 shares of common stock on July 15, 2026 for $5.94 per share.
NASDAQ
Director Michael Ellenbogen reported transactions involving Evolv Technologies Holdings, Inc. (EVLV) Class A Common Stock, including acquisitions and dispositions.
NASDAQ
Evolv Technologies Holdings, Inc. reports a Form 4 filing detailing stock transactions by Chief Revenue Officer Robert E. Marshall.
NASDAQ
Director Michael Ellenbogen reported transactions involving Evolv Technologies Holdings, Inc. Class A Common Stock and stock options on May 15, 2026, executed under a Rule 10b5-1 trading plan.
NASDAQ
Evolv Technologies Holdings, Inc. Chief Financial Officer George Kutsor reported the sale of 51,448 shares of Class A Common Stock to cover withholding taxes related to the vesting of Restricted Stock Units.
NASDAQ
Evolv Technologies Director Michael Ellenbogen exercised options and sold 80,745 shares of Class A Common Stock.
NASDAQ
Evolv Technologies Holdings, Inc. President and CEO John Kedzierski was granted 373,831 Restricted Stock Units.
NASDAQ
Evolv Technologies Holdings, Inc.'s Chief Revenue Officer, Robert E. Marshall, was granted 186,915 Restricted Stock Units, aligning his incentives with shareholder interests.
NASDAQ
Evolv Technologies Holdings' Chief Financial Officer, George C. Kutsor, acquired 186,915 Restricted Stock Units, vesting over three years.
NASDAQ
Evolv Technologies Director Michael Ellenbogen sold 80,745 Class A Common Stock shares for $6.20 each after exercising options.
NASDAQ
Evolv Technologies Holdings CEO John Kedzierski sold 74,322 shares of Class A Common Stock to cover tax obligations following the vesting of 207,000 Restricted Stock Units.
NASDAQ
Evolv Technologies Holdings, Inc. Director Mark J. Sullivan acquired 3,731 Restricted Stock Units, set to vest fully by December 31, 2026.
NASDAQ
Evolv Technologies Director Michael Ellenbogen was granted 3,731 Restricted Stock Units, vesting fully by December 31, 2026, under a Rule 10b5-1 plan.
NASDAQ
Evolv Technologies Holdings, Inc. Director Mark J. Sullivan converted 7,575 Restricted Stock Units into Class A Common Stock following their full vesting on December 31, 2025.
NASDAQ
Evolv Technologies Director Michael Ellenbogen exercised options and sold 80,745 shares of Class A Common Stock for approximately $6.91 per share under a pre-arranged trading plan.
NASDAQ
Evolv Technologies Holdings, Inc.'s Chief Revenue Officer, Robert E Marshall, purchased 7,000 shares of Class A Common Stock at $6.06 per share.
NASDAQ
Evolv Technologies Holdings, Inc. CEO and Director John Kedzierski purchased 8,000 shares of Class A Common Stock on the open market.
NASDAQ
Evolv Technologies Holdings, Inc. Director Kevin M. Charlton reported a planned purchase of 15,000 shares of Class A Common Stock for approximately $85,195.50 under a Rule 10b5-1 plan.
NASDAQ
Evolv Technologies Holdings Director Richard A. Shapiro acquired 46,300 shares of Class A Common Stock across direct and indirect holdings on November 20, 2025.
NASDAQ
Evolv Technologies Director Michael Ellenbogen exercised stock options and subsequently sold 80,745 Class A Common Stock shares for approximately $5.80 per share, as part of a pre-arranged 10b5-1 trading plan.
NASDAQ
Anil Chitkara, Founder & Chief Growth Officer of Evolv Technologies Holdings, Inc., exercised stock options and subsequently sold 360,000 Class A Common Stock shares for approximately $2.95 million.
NASDAQ
Evolv Technologies Director Michael Ellenbogen exercised stock options and subsequently sold 80,745 shares of Class A Common Stock for a weighted average price of $8.26 per share.
NASDAQ
Evolv Technologies' Founder and Chief Innovation Officer, Michael Ellenbogen, exercised options and sold 80,745 Class A Common Stock shares.
NASDAQ
Gates Frontier, LLC and William H. Gates III plan to sell over 1.4 million shares of Evolv Technologies Holdings, Inc. stock in September 2025 under a Rule 10b5-1 plan.
NASDAQ
Evolv Technologies Holdings Director Mark J. Sullivan acquired 26,388 shares of Class A Common Stock through the vesting and conversion of Restricted Stock Units.
NASDAQ
Michael Ellenbogen, Founder and Chief Innovation Officer of Evolv Technologies Holdings, Inc., has transferred investment control of 2,259,987 shares of Class A Common Stock held in a trust to an independent investment advisor, ceasing his beneficial ownership for Section 16 reporting purposes.
NASDAQ
Evolv Technologies Holdings, Inc. Director Richard Shapiro has reported recent acquisitions of Class A Common Stock and Restricted Stock Units, including a delayed filing due to an administrative error.
NASDAQ
Evolv Technologies Holdings, Inc. Director Kevin M. Charlton was granted 27,050 Restricted Stock Units (RSUs) on June 20, 2025, aligning his interests with shareholders.
NASDAQ
Evolv Technologies Holdings, Inc. Director Neil Glat was granted 27,050 Restricted Stock Units (RSUs) on June 20, 2025, aligning his interests with shareholders.
NASDAQ
Evolv Technologies Holdings, Inc. director Kimberly H. Sheehy was granted 27,050 Restricted Stock Units (RSUs) on June 20, 2025, as part of her compensation.